Literature DB >> 6775637

Inhibition of the incorporation of [3H]DOPA in Mycobacterium leprae by desoxyfructo-serotonin.

P Jayaraman, P R Mahadevan, M Mester, L Mester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6775637     DOI： 10.1016/0006-2952(80)90362-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

Review 1.  Pharmacochemical aspects of leprosy. Recent developments and prospects for new drugs.

Authors:  P van Saane; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1989-02-24

2.  The use of an amino acid as a precursor of a bioactive metabolite in combatting an infectious disease: The efficacy of a tryptophan-enriched diet in the treatment of leprosy.

Authors:  J Mauron; R Ganapati; P R Mahadevan; K Anantharaman
Journal:  Amino Acids       Date:  1992-10       Impact factor: 3.520

3.  Utilization of indole compounds by Cryptococcus neoformans to produce a melanin-like pigment.

Authors:  K J Kwon-Chung; W K Tom; J L Costa
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

4.  Metabolism and pharmacokinetics of [14C]-deoxyfructosylserotonin creatinine sulfate administered orally and intravenously to rats and mice.

Authors:  J E Germond; E Gremaud; U Richli; R Badoud; J M Aeschlimann; M J Arnaud
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Apr-Jun       Impact factor: 2.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.